The correlations between chemerin, lipocalin 2 and apelin levels, and demographic and clinical features (patient's age; gravidity; pregestational BMI and BMI at blood collection; weeks of gestation and EFW at blood collection; OGTT hourly glucose concentrations) were evaluated for the GDM group and control group. This evidence concerns the gene RARRES2 and gestational diabetes.